Last reviewed · How we verify
NCT05317429: GlyCarb
Glycaemic Responses to Carbohydrate-rich Meals (GlyCarb)
NA trial testing A meal delivering 75 g of carbohydrate in Glycaemia in 25 participants. Enrolling by invitation.
31 March 2028
Quick facts
| Lead sponsor | Quadram Institute Bioscience |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 25 |
| Start date | 14 February 2022 |
| Primary completion | 31 March 2028 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- A meal delivering 75 g of carbohydrate
Conditions studied
- Glycaemia — all drugs for Glycaemia →
Sponsor
Quadram Institute Bioscience
Who can join
18 and older, any sex, with Glycaemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Carbohydrate-rich foods such as potatoes, bread, rice, pasta, breakfast cereals, biscuits and other snacks are a major component of the human diet. The effect of different carbohydrate-rich foods on blood sugar (glucose) levels after a meal varies between foods. This is relevant to health because studies have shown that regular intake of carbohydrate foods that cause large increases in blood glucose levels after ingestion can be detrimental to metabolic health. The aim of the GlyCarb study is to investigate how food structure influences postprandial glycaemic responses to carbohydrate foods. This will be achieved through a series of acute postprandial studies (up to 5 studies), wherein healthy participants within each postprandial study consume a pair of carbohydrate-rich test meals while wearing a continuous glucose monitoring system (CGM). Each postprandial study will use the same GlyCarb Remote standard protocol, where a randomised cross-over design is used to measure the glycaemic response to two carbohydrate-rich test meals, one "test" and one "control". Both meals will be matched by carbohydrate content, contain similar ingredients and have a similar physical appearance, but will differ in one key food property (e.g., altered food structure) to test its effect on postprandial glycaemia. In each postprandial study, habitual dietary intake and body composition will be captured at baseline as part of the participant characterisation. Participants will consume two different carbohydrate-rich test meals twice, on separate occasions, in a randomly allocated order over a 10 to 14-day period of continuous glucose monitoring. Data from the continuous glucose monitors will be used to assess the postprandial glycaemic response to each carbohydrate food. The participants will be required to complete brief questionnaires designed to evaluate differences in palatability (taste, texture, portion size) and satiety amongst test meals. Study participant feedback will be requested at the end of the study and used to assess and improve future study procedures. The GlyCarb study will enable new understanding of how food properties influence glycaemic responses to different types of carbohydrate foods. Ultimately, the findings will inform the rational design or reformulation of food products and diets to support a healthy glucose metabolism.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of wheat bread with elevated amylose on postprandial glycaemic response: a randomised crossover trial delivered remotely using continuous glucose monitoring.
Corrado M, Savva GM, Ahn-Jarvis JH, Oyeyinka SA, et al · · 2025 · PMID 41277638 · DOI 10.1039/d5fo03147h
Verify or expand the search:
- PubMed search for NCT05317429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Quadram Institute Bioscience trials
Trials by the same sponsor.
- NCT07142759 — Investigating the Impact of Vitamin D Biofortified Tomatoes on Serum Levels of 25(OH)D · NA · enrolling by invitation
- NCT06518343 — Trimethylamine N-oxide Effects of a Pomegranate Supplement Simultaneously With Carnitine (TESSA) · NA · active not recruiting
- NCT06145867 — A Feasibility Study: Assessing Photobiomodulation in Myalgic Encephalomyelitis · NA · enrolling by invitation
- NCT05740462 — Hydroponic Fortification and Dietary App Effect on Nutrients Level (Harvest) · NA · enrolling by invitation
- NCT04546776 — COVID-19 Persistence in Stool · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05317429 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Quadram Institute Bioscience
- Last refreshed: 24 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05317429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing